PRKAA2 and Glucose intolerance: To summarize this section, AX treatment has been seen to: (i) significantly ameliorate insulin resistance and glucose intolerance through AMPK activation; (ii) stimulate mitochondrial biogenesis in the muscle; (iii) enhance exercise tolerance and exercise-induced fatty acid metabolism.